Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dexcom

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

These two companies could present an opportunity for investors to gain access while they are relatively undervalued and before they appreciate once again.

How Is DexCom's Performance Compared to Other Medical Device Companies?

How Is DexCom's Performance Compared to Other Medical Device Companies?

DexCom has outperformed the broader medical devices industry over the past year, and analysts remain strongly bullish on the stock’s prospects.

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

Wall Street gives these three diverse names Strong Buy recommendations with high potential upside.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

DexCom Stock: Analyst Estimates & Ratings

Despite DexCom’s underwhelming price action, Wall Street analysts appear highly optimistic about its prospects.

Dexcom Earnings Beat. Diabetes Device Maker Names New CEO.

Dexcom stock fell late Wednesday as it reported Q2 earnings that topped expectations and named a new chief executive officer.

Investors Business Daily

What You Need to Know Ahead of DexCom’s Earnings Release

DexCom is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.

Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act immediately to protect their health.

International Business Times UK

DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.

Stocks With Rising Relative Strength: DexCom

Stocks With Rising Relative Strength: DexCom

A Relative Strength Rating upgrade for DexCom shows improving technical performance. Will it continue?

Investors Business Daily

Garmin has patented long-term blood glucose tracking; here's how it'd work

Garmin has patented long-term blood glucose tracking; here's how it'd work

Garmin watches already pair with Dexcom for indirect blood glucose monitoring. This patent shows how Garmin watches could directly help diabetics.

Android Central

Do Wall Street Analysts Like DexCom Stock?

Do Wall Street Analysts Like DexCom Stock?

Despite trailing the broader market over the past year, DexCom continues to attract strong optimism from Wall Street analysts, who maintain a highly positive outlook on the stock's long-term potential.

DexCom Stock: Earnings Beat and New Market Access Drive Bull Case

DexCom Stock: Earnings Beat and New Market Access Drive Bull Case

Dexcom's strong quarterly performance and innovative product pipeline signal continued leadership and expansion within the evolving diabetes technology market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Android Central

Oura brings AI-powered meals and glucose tracking to the US

Oura launches two metabolic features within the Oura app that help users track their meals, rise in glucose levels to manage their eating habits.

Investors Business Daily

Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device

Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day period.

Is DexCom Stock Underperforming the Dow?

DexCom significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s long term prospects.

Investors Business Daily

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.

Get all your
news in one place.

100’s of premium titles.
One news app.

DexCom Stock Outlook: Is Wall Street Bullish or Bearish?

Although DexCom has significantly lagged behind the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Investors Business Daily

Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

What to Expect From DexCom's Q4 2024 Earnings Report

DexCom is gearing up to release its fourth-quarter earnings next month, and analysts forecast single-digit profit growth.

Android Central

The Oura Ring is about giving your body a voice, says Oura CEO

The Oura Ring 4 set a standard in the smart ring industry, and its CEO is excited for the future to make Oura the ring connected to our health.

Is DexCom Stock Underperforming the Nasdaq?

Despite DexCom's lagging performance relative to the Nasdaq Composite over the past year, Wall Street analysts maintain a strong bullish outlook on the stock's prospects.

Key Takeaways From DexCom Analyst Ratings

DexCom (NASDAQ:DXCM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor is more affordable and accessible, but how well does it work for diabetics?

People

Robert F. Kennedy Jr

Brandon Vazquez

Margaret Kaczor Andrew

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Android Central

Investor Business Daily

the Food and Drug Administration

Abbott Laboratories

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

303,347 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play